Payment overview · 2025
General Payments
$13.82
1 reported records · 1 companies
Healthcare provider profile · identity verified
Daniel Bubenheim, MD
Allopathic & Osteopathic Physicians|Family Medicine · PITTSBURGH, PA · NPI 1790758035
Verified facts
What the public records show
CMS Open Payments records show Daniel Bubenheim, MD received $13.82 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 284 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $13.82 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $13.82 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $13.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 284 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
284 | 50 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1295 | 250 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1243 | 298 |
| Omeprazole | Omeprazole | 861 | 175 |
| Amlodipine Besylate | Amlodipine Besylate | 849 | 196 |
| Lactulose | Lactulose | 613 | 25 |
| Losartan Potassium | Losartan Potassium | 537 | 136 |
| Lisinopril | Lisinopril | 510 | 140 |
| Simvastatin | Simvastatin | 499 | 125 |
| Tamsulosin Hcl | Tamsulosin Hcl | 496 | 97 |
| Metformin Hcl | Metformin Hcl | 463 | 127 |
| Furosemide | Furosemide | 459 | 93 |
| Gabapentin | Gabapentin | 452 | 80 |
| Pantoprazole Sodium | Pantoprazole Sodium | 446 | 87 |
| Alprazolam | Alprazolam | 397 | 95 |
| Metoprolol Tartrate | Metoprolol Tartrate | 350 | 82 |
| Fluticasone Propionate | Fluticasone Propionate | 333 | 90 |
| Potassium Chloride | Potassium Chloride | 314 | 67 |
| Hydrochlorothiazide | Hydrochlorothiazide | 297 | 79 |
| Eliquis | Apixaban | 284 | 50 |
| Ozempic | Semaglutide | 284 | 50 |
| Allopurinol | Allopurinol | 282 | 54 |
| Citalopram Hbr | Citalopram Hydrobromide | 278 | 55 |
| Levetiracetam | Levetiracetam | 274 | 34 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 273 | 72 |
| Sertraline Hcl | Sertraline Hcl | 269 | 62 |
| Famotidine | Famotidine | 261 | 53 |
| Duloxetine Hcl | Duloxetine Hcl | 253 | 49 |
| Metoprolol Succinate | Metoprolol Succinate | 236 | 65 |
| Carvedilol | Carvedilol | 218 | 46 |
| Azithromycin | Azithromycin | 216 | 168 |
| Montelukast Sodium | Montelukast Sodium | 206 | 35 |
| Glimepiride | Glimepiride | 191 | 51 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 184 | 62 |
| Lamotrigine | Lamotrigine | 184 | 13 |
| Synthroid | Levothyroxine Sodium | 180 | 44 |
| Methylprednisolone | Methylprednisolone | 178 | 138 |
| Tramadol Hcl | Tramadol Hcl | 160 | 43 |
| Alendronate Sodium | Alendronate Sodium | 158 | 33 |
| Memantine Hcl | Memantine Hcl | 157 | 31 |
| Atenolol | Atenolol | 153 | 45 |
| Trazodone Hcl | Trazodone Hcl | 147 | 37 |
| Donepezil Hcl | Donepezil Hcl | 146 | 34 |
| Escitalopram Oxalate | Escitalopram Oxalate | 141 | 31 |
| Ezetimibe | Ezetimibe | 140 | 36 |
| Lorazepam | Lorazepam | 132 | 39 |
| Zolpidem Tartrate | Zolpidem Tartrate | 132 | 28 |
| Finasteride | Finasteride | 127 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 124 | 28 |
| Januvia | Sitagliptin Phosphate | 123 | 29 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 121 | 31 |
| Phenobarbital | Phenobarbital | 120 | suppressed |
| Prednisone | Prednisone | 115 | 65 |
| Topiramate | Topiramate | 115 | 13 |
| Clopidogrel | Clopidogrel Bisulfate | 114 | 35 |
| Meloxicam | Meloxicam | 114 | 24 |
| Spironolactone | Spironolactone | 113 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 111 | 18 |
| Meclizine Hcl | Meclizine Hcl | 108 | 35 |
| Amoxicillin | Amoxicillin | 105 | 67 |
| Fluoxetine Hcl | Fluoxetine Hcl | 105 | 26 |
| Valsartan | Valsartan | 103 | 24 |
| Clonazepam | Clonazepam | 102 | 13 |
| Mirtazapine | Mirtazapine | 102 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 100 | 20 |
| Ibuprofen | Ibuprofen | 96 | 34 |
| Warfarin Sodium | Warfarin Sodium | 96 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 95 | 51 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 91 | 70 |
| Buspirone Hcl | Buspirone Hcl | 91 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 89 | 23 |
| Bupropion Xl | Bupropion Hcl | 88 | 17 |
| Lansoprazole | Lansoprazole | 88 | 13 |
| Divalproex Sodium | Divalproex Sodium | 86 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 85 | 21 |
| Metoclopramide Hcl | Metoclopramide Hcl | 84 | suppressed |
| Baclofen | Baclofen | 83 | 12 |
| Celecoxib | Celecoxib | 83 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 79 | 23 |
| Diclofenac Sodium | Diclofenac Sodium | 78 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 76 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 75 | 18 |
| Jardiance | Empagliflozin | 73 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 72 | 27 |
| Scopolamine | Scopolamine | 72 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 72 | 20 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 72 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 70 | 15 |
| Solifenacin Succinate | Solifenacin Succinate | 70 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 66 | 45 |
| Ondansetron Hcl | Ondansetron Hcl | 66 | 35 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 65 | 39 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 65 | 51 |
| Xarelto | Rivaroxaban | 65 | 12 |
| Lacosamide | Lacosamide | 63 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 63 | 14 |
| Ketoconazole | Ketoconazole | 62 | 25 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 58 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 57 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 56 | 15 |
| Mupirocin | Mupirocin | 55 | 38 |
| Sucralfate | Sucralfate | 54 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 53 | 16 |
| Bumetanide | Bumetanide | 53 | 12 |
| Cephalexin | Cephalexin | 53 | 40 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 53 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 49 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 49 | 12 |
| Risperidone | Risperidone | 48 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 48 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 47 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 43 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 43 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 41 | 35 |
| Erythromycin Ethylsuccinate | Erythromycin Ethylsuccinate | 41 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 41 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 40 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 38 | suppressed |
| Diazepam | Diazepam | 37 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 37 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 37 | suppressed |
| Pregabalin | Pregabalin | 36 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 36 | 22 |
| Carbamazepine | Carbamazepine | 34 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 34 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 34 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 33 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 33 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | suppressed |
| Irbesartan | Irbesartan | 32 | suppressed |
| Jantoven | Warfarin Sodium | 32 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 32 | 32 |
| Breo Ellipta | Fluticasone/Vilanterol | 31 | suppressed |
| Hydrocortisone | Hydrocortisone | 31 | 19 |
| Levocarnitine | Levocarnitine (With Sugar) | 31 | suppressed |
| Repatha Sureclick | Evolocumab | 31 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 30 | suppressed |
| Nystatin | Nystatin | 30 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 29 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 28 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 28 | suppressed |
| Erythromycin | Erythromycin Base | 27 | suppressed |
| Ibu | Ibuprofen | 27 | 11 |
| Ranolazine Er | Ranolazine | 27 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 27 | 12 |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Digoxin | Digoxin | 26 | suppressed |
| Felbamate | Felbamate | 26 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 26 | suppressed |
| Nystop | Nystatin | 26 | 12 |
| Repaglinide | Repaglinide | 26 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 25 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 25 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 25 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 25 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 25 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 24 | suppressed |
| Clobazam | Clobazam | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 23 | suppressed |
| Nifedipine Er | Nifedipine | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 22 | suppressed |
| Mesalamine | Mesalamine | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Fluconazole | Fluconazole | 21 | 15 |
| Klor-Con M20 | Potassium Chloride | 21 | suppressed |
| Linzess | Linaclotide | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 11 |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 20 | suppressed |
| Colchicine | Colchicine | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | 13 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 20 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 19 | suppressed |
| Indomethacin | Indomethacin | 19 | suppressed |
| Latanoprost | Latanoprost | 19 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 18 | 16 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 18 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 18 | suppressed |
| Budesonide | Budesonide | 17 | suppressed |
| Naproxen | Naproxen | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Rivastigmine | Rivastigmine | 17 | suppressed |
| Rytary | Carbidopa/Levodopa | 17 | suppressed |
| Tobramycin | Tobramycin | 17 | 17 |
| Albuterol Sulfate | Albuterol Sulfate | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Restasis | Cyclosporine | 16 | suppressed |
| Rufinamide | Rufinamide | 16 | suppressed |
| Safetyglide Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Low-Ogestrel | Norgestrel-Ethinyl Estradiol | 15 | suppressed |
| Ssd | Silver Sulfadiazine | 15 | suppressed |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Tacrolimus | Tacrolimus | 15 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 14 | suppressed |
| Clotrimazole | Clotrimazole | 14 | 11 |
| Kurvelo | Levonorgestrel/Ethin.Estradiol | 14 | suppressed |
| Nateglinide | Nateglinide | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Rybelsus | Semaglutide | 14 | suppressed |
| Sulfasalazine | Sulfasalazine | 14 | suppressed |
| Sulindac | Sulindac | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 13 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Desloratadine | Desloratadine | 13 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 13 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 13 | suppressed |
| Entresto | Sacubitril/Valsartan | 13 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 13 | suppressed |
| Modafinil | Modafinil | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Mysoline | Primidone | 13 | suppressed |
| Prolia | Denosumab | 13 | suppressed |
| Alogliptin | Alogliptin Benzoate | 12 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Cabergoline | Cabergoline | 12 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Tiagabine Hcl | Tiagabine Hcl | 12 | suppressed |
| Ursodiol | Ursodiol | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Neupogen | Filgrastim | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $13.82 · 1 records | Novo Nordisk Inc | Ozempic | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error